First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...
Zytiga sales have been romping away of late in part because of the results of the LATITUDE study in metastatic high-risk castration sensitive prostate cancer, which firmed up its competitive ...
Approval of the drug for men with prostate cancer that has spread but has not yet become hormone resistant, would step up pressure on rival therapy Zytiga (abiraterone acetate) from Johnson ...
It was designed as an alternative abiraterone acetate formulation with clear benefits over branded Zytiga tablets. TAVT-45 granules are rapidly reconstituted in water or juice and easily consumed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results